Search results for "allogeneic mesenchymal"

MediPost Begins Pivotal U.S. Phase 3 Trial for Regenerative Knee Therapy Cartistem

MediPost Begins Pivotal U.S. Phase 3 Trial for Regenerative Knee Therapy Cartistem

South Korean biotechnology company MediPost has entered full-scale Phase 3 clinical testing in the United States for its landmark knee osteoarthritis...
More Stem Cells Doesn't Mean Better Results: Why Cell Count Alone Falls Short

More Stem Cells Doesn't Mean Better Results: Why Cell Count Alone Falls Short

Following the box-office success of the film Spider-Man: Brand New Day, public attention has once again turned to Lizard, the series' iconic villain...
FDA Grants Streamlined Path for MediPost’s Cartistem, Slashing U.S. Trial Burden

FDA Grants Streamlined Path for MediPost’s Cartistem, Slashing U.S. Trial Burden

The U.S. Food and Drug Administration has agreed to a significantly streamlined clinical path for Cartistem, a landmark...